Newborns' cord blood plasma cotinine concentrations are similar to that of their delivering smoking mothers

Drug and Alcohol Dependence

Volumn 107, Issue 2-3, 2010, Pages 250-252

  Berlin, Ivan ^a   Heilbronner, Claire ^b   Georgieu, Sabine ^c   Meier, Cathy ^d   Spreux Varoquaux, Odile ^e  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CENTRE HOSPITALIER DE LA CÔTE BASQUE   (France)

^d CENTRE HOSPITALIER DE PAU   (France)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

Labor; Newborns; Plasma cotinine; Umbilical cord blood

Indexed keywords

COTININE;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD PLACENTA BARRIER; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; FEMALE; HUMAN; MALE; MATERNAL SMOKING; NEWBORN; PERINATAL MORBIDITY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ADULT; COTININE; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; PLACENTA; PREGNANCY; SMOKING; TOBACCO USE DISORDER;

NICOTIANA TABACUM;

EID: 77649180883     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.10.008     Document Type: Article

References (15)

1. Benowitz N.L., Kuyt F., Jacob P., Jones R.T., Osman A.L. Cotinine disposition and effects. Clin. Pharmacol. Ther. 1983, 34:604-611.
2. Berlin I., Heilbronner C., Georgieu S., Meier C., Launay J.M., Spreux-Varoquaux O. Reduced monoamine oxidase A activity in pregnant smokers and in their newborns. Biol. Psychiatry 2009, 66:728-733.
3. Curvall M., Elwin C.E., Kazemi-Vala E., Warholm C., Enzell C.R. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur. J. Clin. Pharmacol. 1990, 38:281-287.
4. Dempsey D., Jacob P., Benowitz N.L. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J. Pharmacol. Exp. Ther. 2002, 301:594-598.
5. Donnenfeld A.E., Pulkkinen A., Palomaki G.E., Knight G.J., Haddow J.E. Simultaneous fetal and maternal cotinine levels in pregnant women smokers. Am. J. Obstet. Gynecol. 1993, 168:781-782.
6. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. Brit. J. Addict. 1991, 86:1119-1127.
7. Hariharan M., Vannoord T., Greden J.F. A high-performance liquid chromatographic method for routine simultaneous determination of nicotine and cotinine in plasma. Clin. Chem. 1988, 34:724-729.
8. Hayde M., Bernaschek G., Stevenson D.K., Knight G.J., Haddow J.E., Widness J.A. Acta Paediatr. 1999, 88:327-331.
9. Hukkanen J., Jacob P., Benowitz N.L. Metabolism and disposition kinetics of nicotine. Pharmacol. Rev. 2005, 57:79-115.
10. Nafstad P., Kongerud J., Botten G., Urdal P., Silsand T., Pedersen B.S., Jaakola J.J.K. Fetal exposure to tobacco smoke products: a comparison between self-reported maternal smoking and concentrations of cotinine and thiocyanate in cord serum. Acta Obstet. Gynecol. Scand. 1996, 75:902-907.
11. Sastry B.V.R., Chance M.B., Hemontolor M.E., Goddijn-Wessel T.A.W. Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon. Pharmacology 1998, 57:104-116.
12. Sastry B.V.R., Hemontolor M.E., Olenick M. Prostaglandin E2 in human placenta: its vascular effects and activation of prostaglandin E2 formation by nicotine and cotinine. Pharmacology 1999, 58:70-86.
13. SRNT Subcommittee on Biochemical Verification Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 2002, 4:149-159.
14. Pastrakuljic A., Schwartz R., Simone C., Derewlany L.O., Knie B., Koren G. Transplacental transfer and biotransformation studies of nicotine in the human placental cotyledon perfused in vitro. Life Sci. 1998, 63:2333-2342.
15. Pichini S., Basagna X., Pacifici R., Garcia O., Puig C., Vall O., Harris J., Zuccaro P., Segura J., Sunyer J. Cord serum cotinine as a biomarker of fetal exposure to cigarette smoke at the end of pregnancy. Environ. Health Perspect. 2000, 108:1079-1083.